当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:44.97亿  总市值:54.54亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,867,794,372.087,452,744,440.475,260,619,409.23,952,480,341.22
  收到的税费返还1,668,911.38110,500,140.59108,310,353.96107,000,632.15
  收到其他与经营活动有关的现金34,913,541.85236,827,579.41136,570,606.9438,985,879.24
  经营活动现金流入小计1,904,376,825.317,800,072,160.475,505,500,370.14,098,466,852.61
  购买商品、接受劳务支付的现金1,448,224,402.317,042,998,295.62,764,527,990.552,007,927,012.73
  支付给职工以及为职工支付的现金69,898,876.43265,016,266.31199,120,296.94129,978,141.6
  支付的各项税费34,262,468.37102,134,495.278,382,058.9159,416,285.81
  支付其他与经营活动有关的现金75,130,399.52177,016,134.37126,910,294.7971,408,773.13
  经营活动现金流出小计1,627,516,146.637,587,165,191.483,168,940,641.192,268,730,213.27
  经营活动产生的现金流量净额276,860,678.68212,906,968.992,336,559,728.911,829,736,639.34
二、投资活动产生的现金流量:
  收回投资收到的现金663,253,377.8820,497,3063,564,165,891.41,755,275,796.4
  取得投资收益收到的现金1,577,267.8869,519,259.9852,109,337.2833,969,630.04
  处置固定资产、无形资产和其他长期资产收回的现金净额18,1094,481,8384,478,3824,381,729.22
  处置子公司及其他营业单位收到的现金净额--277,970.65--
  投资活动现金流入小计664,848,754.68894,220,433.333,620,753,610.681,793,627,155.66
  购建固定资产、无形资产和其他长期资产支付的现金25,987,217.95135,256,502.9293,486,973.0455,852,452.98
  投资支付的现金1,880,543,455.3767,461,886.563,813,357,722.033,060,619,929.27
  投资活动现金流出小计1,906,530,673.25902,718,389.483,906,844,695.073,116,472,382.25
  投资活动产生的现金流量净额-1,241,681,918.57-8,497,956.15-286,091,084.39-1,322,845,226.59
三、筹资活动产生的现金流量:
  取得借款收到的现金2,114,997,315.445,975,814,035.91,789,690,035.91,965,690,035.9
  收到其他与筹资活动有关的现金-20,620,000--
  筹资活动现金流入小计2,114,997,315.445,996,434,035.91,789,690,035.91,965,690,035.9
  偿还债务支付的现金620,600,0005,766,417,225.162,878,667,225.161,603,829,488.96
  分配股利、利润或偿付利息支付的现金31,881,963.94159,853,624.51138,353,989.85125,010,139.4
  支付其他与筹资活动有关的现金60,207,160711,0041,696,626.491,693,835
  筹资活动现金流出小计712,689,123.945,926,981,853.673,018,717,841.51,730,533,463.36
  筹资活动产生的现金流量净额1,402,308,191.569,452,182.23-1,229,027,805.6235,156,572.54
四、汇率变动对现金及现金等价物的影响1,217,453.22-3,622,724.59-4,979,642.25-2,226,398.82
五、现金及现金等价物净增加额438,704,404.83270,238,470.48816,461,196.67739,821,586.47
  加:期初现金及现金等价物余额785,040,710.5514,802,240.02514,802,240.02514,802,240.02
  期末现金及现金等价物余额1,223,745,115.33785,040,710.51,331,263,436.691,254,623,826.49
补充资料:
  净利润-374,875,475.85-221,253,745.12
  资产减值准备-39,220,328.62-13,183,693.56
  固定资产和投资性房地产折旧-173,626,497.04-84,586,334.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-173,626,497.04-84,586,334.61
  无形资产摊销-9,740,074.75-4,817,267.04
  长期待摊费用摊销-214,408.32-100,000.02
  处置固定资产、无形资产和其他长期资产的损失--1,457,326.99--3,982,574.33
  固定资产报废损失-168,512.41-48,622.16
  公允价值变动损失--9,273,528.3--2,296,924.13
  财务费用-90,825,719.52-58,758,941.51
  投资损失--46,353,968.87--27,436,415.66
  递延所得税-8,424,746.1-10,740,485.68
  其中:递延所得税资产减少-1,609,208.12-11,403,111.55
    递延所得税负债增加-6,815,537.98--662,625.87
  存货的减少--391,834,718.99-1,567,849,044.57
  经营性应收项目的减少--8,244,979.44-49,111,465.11
  经营性应付项目的增加--31,405,046.97--145,556,542.22
  现金的期末余额-785,040,710.5-1,254,623,826.49
  减:现金的期初余额-514,802,240.02-514,802,240.02
  现金及现金等价物的净增加额-270,238,470.48-739,821,586.47
公告日期2026-04-252026-03-312025-10-252025-08-26
审计意见(境内)标准无保留意见
TOP↑